Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Insulet Corporation (PODD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Insulet's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
231.18 -4.96    -2.10%
29/09 - Closed. Currency in USD ( Disclaimer )
After Hours
231.18
0.00
0.00%
21:34:32 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 226,848
  • Bid/Ask: 230.99 / 233.12
  • Day's Range: 227.15 - 234.63
Insulet 231.18 -4.96 -2.10%

Insulet Corporation Company Profile

 
Get an in-depth profile of Insulet Corporation, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealth Care Equipment & Supplies
SectorHealthcare
Employees

2300

Equity Type

ORD

Insulet Corporation is primarily engaged in the development, manufacture and sale of its Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.

Contact Information

Phone 978 600 7000
Fax 978 600 0120

Top Executives

Name Age Since Title
Timothy J. Scannell 56 2014 Independent Chairman
Margaret Lawlor - - Member of Educator Advisory Board
Howard Wolpert - - Member of Scientific Advisory Board
John B. Buse - - Member of Scientific Advisory Board
Anne Daly - - Member of Educator Advisory Board
Michael R. Minogue 55 2017 Independent Director
Mary Halvorson - - Member of Educator Advisory Board
Barbara J. Anderson - - Member of Educator Advisory Board
Robert S. Sherwin - - Chairman of Scientific Advisory Board
James R. Hollingshead 59 2019 President, CEO & Director
Luciana Borio 50 2021 Independent Director
Shacey Petrovic 48 2016 Director & Advisor
Camille Izlar - - Member of Educator Advisory Board
Steven V. Edelman 66 - Member of Scientific Advisory Board
Jessica Hopfield 57 2015 Director
Wayne Alix-Ian Frederick 50 2020 Independent Director
Corinne H. Nevinny 62 2019 Independent Director
Elizabeth H. Weatherman 62 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PODD Comments

Write your thoughts about Insulet Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email